Institute of Neurological Sciences, National Research Council, Loc. Burga, 87050, Piano Lago di Mangone (CS), Italy.
Neurol Sci. 2011 Feb;32(1):95-9. doi: 10.1007/s10072-010-0416-0. Epub 2010 Sep 22.
L-2-Hydroxyglutaric aciduria (L-2-HGA) is a neurometabolic disease characterized by the presence of elevated levels of 2-hydroxyglutaric acid in the plasma, cerebrospinal fluid and urine. Clinical features in this inherited condition consist of mental deterioration, ataxia and motor deficits with pyramidal and extrapyramidal symptoms and signs. L-2-HGA is caused by mutations in the L-2-HGDH gene which most probably encodes for a L-2-hydroxyglutarate dehydrogenase, a putative mitochondrial protein converting L-2-hydroxyglutarate to alphaketoglutarate. Here, we report a pathogenic nonsense mutation in the L-2-HGDH gene found for the first time in an Italian patient affected by L-2-HGA, reinforcing the previously described phenotype of this rare metabolic disease and confirming the data indicating that mutations in the L-2-HGDH gene cause L-2-HGA.
L-2-羟戊二酸尿症(L-2-HGA)是一种神经代谢疾病,其特征是血浆、脑脊液和尿液中 2-羟戊二酸水平升高。这种遗传性疾病的临床特征包括精神恶化、共济失调和运动功能障碍,伴有锥体束和锥体外系症状和体征。L-2-HGA 是由 L-2-HGDH 基因突变引起的,该基因突变最有可能编码 L-2-羟戊二酸脱氢酶,这是一种假定的线粒体蛋白,将 L-2-羟戊二酸转化为α-酮戊二酸。在这里,我们报告了在一名意大利 L-2-HGA 患者中首次发现的 L-2-HGDH 基因的致病性无义突变,这进一步证实了这种罕见代谢疾病的先前描述的表型,并确认了突变导致 L-2-HGA 的相关数据。